Joe Pierce,  —

Recent Posts

• Screening underway for microdose psilocybin trial in Canada
• Oral allopregnanolone for FXTAS to be tested in PureTech’s Phase 2 trial
• Participate in Fragile X Awareness Month with lights, social media posts, and more
• Allos plans for pivotal Phase 3 study of arbaclofen for fragile X
• ADHD more likely in certain fragile X premutation carriers: Study
• Zygel continues to improve youngsters’ behavior, long-term data show
• Highly-sensitive blood test may improve FXS prognosis
• Sound processing, behaviors linked in women with fragile X premutations
• Mouse study links fragile X to abnormal protein degradation
• Gruber Prize goes to discovery of NMD